Literature DB >> 729281

Metastatic cancer of the spinal column.

W B Kleinman, H A Kiernan, W J Michelsen.   

Abstract

In an effort to determine the potential of radiotherapy or surgery in alleviating the symptoms and signs of metastic cancer to the spinal neuraxis, 77 cases with documented malignant disease in this area were studied retrospectively over a 2 year period. Emphasis must be placed on early diagnosis, and recognition of intractable day and night pain as a hallmark of cancer of the spine. This symptom was found to be present for many months before the diagnosis could be made on plain X-rays. Bone-scanning, tomography, and myelography were consistently found to be useful adjuncts to early diagnosis. This study points out that operative intervention is ineffective in relieving the signs and symptoms of cord compromise, and adds significantly to the general morbidity of the patient. This was a consistent finding in cases with metastases to the thoracic spine who had developed neurological dysfunction secondary to their tumors. Radiation therapy should be considered a useful form of palliation for the pain associated with metastatic cancer.

Entities:  

Mesh:

Year:  1978        PMID: 729281

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Epidural compression from metastatic tumor with resultant paralysis.

Authors:  F L Ampil
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

2.  Adverse effects of the management of malignant spinal cord compression.

Authors:  G F Findlay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

3.  Spinal intradural metastases of extraneural origin.

Authors:  B Borovich; D Keret; J Ben-Arie; I Grushkiewicz; E Peyser
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

4.  Outcome after limited posterior surgery for thoracic and lumbar spine metastases.

Authors:  B Jónsson; L Sjöström; C Olerud; I Andréasson; J Bring; W Rauschning
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.